Related people
Sherin Sayed
Sherin is a member of the Practice Area Patents Technology & Life Sciences. She advises national and international companies on general issues of medical device law and pharmaceutical law, in particular with regard to regulatory issues. Her practice focuses on life sciences.
Show full CV
Hide full CV
More
Show less
More
Show less
Career
| Since 2022 | Associate, Taylor Wessing |
| 2022 | Legal Counsel, Consulting firm |
| 2020 - 2022 | Legal Trainee, Higher Legal Court of Munich |
| 2020 - 2021 | Research Assistent, Ludwig-Maximilians-University of Munich |
| 2020 | Research Assistent, law firm |
| 2017 - 2020 | Student Assistant, Ludwig-Maximilians-University of Munich |
Education
| 2022 | Admitted as a lawyer, Munich |
| 2022 | Second state examination, Munich |
| 2020 | First state examination, Munich |
| 2015 | Law studies, Ludwig-Maximilians-University of Munich |
Publications
Überraschungsentscheidungen, in: GRUR-Prax 2024, together with Manja Epping „Werbung für Arzneimittel“ auch bei Bezug zu unbestimmten Arzneimitteln gegeben, in: GRUR-Prax, 2023 |
Additional languages
| English |
Latest news & insights
Patents & innovation
Click here to find out more
Important for start-ups: Confidentiality Agreements and Material Transfer Agreements (MTAs)
27 March 2024
Briefing
Corporate/M&A & capital markets
Click here to find out more
Bertelsmann Investments acquires pharma tech company EXTEDO with Taylor Wessing
27 February 2024
by multiple authors
Corporate/M&A & capital markets
Click here to find out more
Taylor Wessing advises Sunday Natural on the sale of a stake to CVC
16 January 2024
by multiple authors
Patents & innovation
Click here to find out more
JUVE Awards 2023: Taylor Wessing named "Law Firm of the Year for IP”
27 October 2023
by multiple authors